About 23 results found for searched term "Proton Pump" (0.092 seconds)
Cat.No. | Name | Target |
---|---|---|
M1834 | Omeprazole (H 16868) | Proton Pump |
H 16868; Omeprazol | ||
Omeprazol is a first-in-class proton pump inhibitor (PPI) used in the treatment of dyspepsia, laryngopharyngeal reflux (LPR) and Zollinger–Ellison syndrome. | ||
M2627 | Dexlansoprazole | Proton Pump |
Dexlansoprazole, the dextrorotatory enantiomer of lansoprazole, is a proton pump inhibitor (PPI) formulated to have dual delayed-release properties. | ||
M3056 | Tenatoprazole | Proton Pump |
Tenatoprazole is a procompound of the proton pump inhibitor (PPI) class, which inhibits proton transport with IC50 of 3.2 μM. | ||
M3137 | Zinc Pyrithione | Cuproptosis |
ZnPyr | ||
Zinc Pyrithione is an anti-fungal and anti-bacterial drug that disrupts membrane transport by blocking proton pumps and is a potent copper ion carrier that can be used in copper death (cuproptosis) studies. | ||
M3448 | Esomeprazole Sodium | Proton Pump |
(S)-Omeprazole sodium | ||
Esomeprazole Sodium is a sodium salt of esomeprazole that is a potent proton pump inhibitor with an IC50 of 0.076 mg/kg. | ||
M3575 | Esomeprazole Magnesium | Proton Pump |
Esomeprazole Magnesium is a proton pump inhibitor to reduce gastric acid secretion. | ||
M3707 | Rabeprazole Sodium | Proton Pump |
LY307640 sodium | ||
Rabeprazole is a frequently used second-generation proton pump inhibitor (PPI) that irreversibly inactivates gastric H+/K+-ATPase. | ||
M1583 | Omeprazole sulfone | Metabolite/Endogenous Metabolite |
Omeprazole sulfone; Omeprazole sulphone | ||
Omeprazole sulfone is a metabolite of Omeprazole, which is a proton pump inhibitor. | ||
M5633 | Pantoprazole sodium | Proton Pump |
SKF96022 sodium, BY-1023 sodium | ||
Pantoprazole is a proton pump inhibitor drug that inhibits gastric acid secretion. It works on gastric parietal cells to irreversibly inhibit (H+/K+)-ATPase function and suppress the production of gastric acid. | ||
M5728 | Lansoprazole | Proton Pump |
A-65006, AG-1749 | ||
Lansoprazole is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid. | ||
M6194 | Esomeprazole Magnesium trihydrate | Autophagy |
(S)-Omeprazole magnesium trihydrate | ||
Esomeprazole Magnesium trihydrate is a proton pump inhibitor which reduces acid secretion through inhibition of the H+ / K+ ATPase in gastric parietal cells. | ||
M14265 | Pantoprazole sodium hydrate | Proton Pump |
BY1023 sodium hydrate; SKF96022 sodium hydrate | ||
Pantoprazole sodium hydrate (BY10232 sodium hydrate) is an orally active and potent proton pump inhibitor (PPI). Pantoprazole sodium hydrate is also a potent H+/K+-ATPase inhibitor with an IC50 of 6.8 μM. | ||
M20397 | Pantoprazole | Proton Pump |
Pantoprazole is a proton pump inhibitor used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease. | ||
M20434 | Rabeprazole | Proton Pump |
Rabeprazole is an orally active proton pump inhibitor that inhibits gastric acid secretion by interacting with (H+/K+)-ATPase in gastric lining cells. In addition, Rabeprazole significantly inhibits the activity of Helicobacter pylori and may be used in studies related to various digestive disorders. | ||
M20452 | Revaprazan Hydrochloride | Proton Pump |
YH1885 | ||
Revaprazan Hydrochloride is a new reversible proton pump inhibitor with long-lasting acid-suppressive effects. | ||
M20496 | Ilaprazole sodium | Proton Pump |
IY-81149 sodium | ||
Ilaprazole sodium is the sodium salt form of ilaprazole, which is a proton pump inhibitor. | ||
M20514 | Omeprazole Sodium | Proton Pump |
Omeprazole Sodium is the sodium salt form of omeprazole, which is a proton pump inhibitor and suppresses gastric acid secretion. | ||
M20547 | Rabeprazole Related Compound E | Proton Pump |
Rabeprazole thioether; Rabeprazole Sulfide | ||
Rabeprazole Related Compound E is the active metabolite of Rabeprazole and an orally active proton pump inhibitor that inhibits gastric acid secretion by interacting with (H+/K+)-ATPase in gastric lining cells. In addition, Rabeprazole Related Compound E significantly inhibits the activity of Helicobacter pylori and can be used in studies related to various digestive disorders. | ||
M20570 | Ufiprazole | Others |
Omeprazole sulfide | ||
Ufiprazole (Omeprazole sulfide) is an intermediate used in the production of the gastric proton pump inhibitors omeprazole and esomeprazole. | ||
M29007 | Abeprazan | Proton Pump |
DWP14012; Fexuprazan | ||
Abeprazan (DWP14012) is a potassium-competitive acid blocker. Abeprazan inhibits H+, K+- ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan is developed as a potential alternative to proton pump inhibitor for the treatment of acid-related diseases. | ||
M29008 | Abeprazan hydrochloride | Proton Pump |
DWP14012 hydrochloride; Fexuprazan hydrochloride | ||
Abeprazan hydrochloride (DWP14012 hydrochloride) is a potassium-competitive acid blocker. Abeprazan hydrochloride inhibits H+, K+- ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan hydrochloride is developed as a potential alternative to proton pump inhibitor for the treatment of acid-related diseases. | ||
M29058 | Vonoprazan hydrochloride | Proton Pump |
TAK-438 hydrochloride | ||
Vonoprazan hydrochloride, a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan hydrochloride inhibits H+,K+-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5. | ||
M29085 | Revaprazan | Proton Pump |
SB 641257 | ||
Revaprazan (SB 641257) is a reversible proton pump inhibitor with significant anti-inflammatory effects. Revaprazan can be used for chronic gastric inflammation research. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.